March 01, 1999; 52 (5) Articles
Restless legs syndrome improved by pramipexole
A double-blind randomized trial
Jacques Montplaisir, Alain Nicolas, Régine Denesle, Baltazar Gomez-Mancilla
First published March 1, 1999, DOI: https://doi.org/10.1212/WNL.52.5.938
Jacques Montplaisir
MD, PhD, CRCPc
Alain Nicolas
MD, PhD
Régine Denesle
BA
Baltazar Gomez-Mancilla
MD, PhD
Restless legs syndrome improved by pramipexole
A double-blind randomized trial
Jacques Montplaisir, Alain Nicolas, Régine Denesle, Baltazar Gomez-Mancilla
Neurology Mar 1999, 52 (5) 938; DOI: 10.1212/WNL.52.5.938
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 52 no. 5 938
PubMed:
Print ISSN:
Online ISSN:
History:
- Received August 5, 1998
- Accepted November 14, 1998
- First Published March 1, 1999.
Copyright & Usage:
© 1999
Author Disclosures
- Jacques Montplaisir, MD, PhD, CRCPc,
- Alain Nicolas, MD, PhD,
- Régine Denesle, BA and
- Baltazar Gomez-Mancilla, MD, PhD
- Jacques Montplaisir, MD, PhD, CRCPc,
- Alain Nicolas, MD, PhD,
- Régine Denesle, BA and
- Baltazar Gomez-Mancilla, MD, PhD
- From the Centre d’Étude du Sommeil (Dr. Montplaisir and R. Denesle)Hôpital du Sacré-Coeur de Montréal, Québec, Canada; INSERM U480 (Dr. Nicolas), Centre Hospitalier Lyon-Sud, Pierre-Bénite, France; and CNS/Development, Pharmacia and Upjohn Inc. (Dr. Gomez-Mancilla), Kalamazoo, MI.
- Address correspondence and reprint requests to Dr. Jacques Montplaisir, Centre d’Étude du Sommeil, Hôpital du Sacré-Coeur de Montréal, 5400 Boul. Gouin Ouest, Montréal, Québec, H4J 1C5, Canada.
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
Efficacy of cabergoline in restless legs syndromeA placebo-controlled study with polysomnography (CATOR)W. H. Oertel, H. Beneš, R. Bodenschatz et al.Neurology, August 23, 2006 -
Articles
New paradigms in the treatment of restless legs syndromeMichael J. Thorpy et al.Neurology, June 27, 2005 -
Articles
A randomized controlled study of pergolide in patients with restless legs syndromeT.C. Wetter, K. Stiasny, J. Winkelmann et al.Neurology, March 01, 1999 -
Articles
Preferential D2 or preferential D3 dopamine agonists in restless legs syndromeM. Manconi, R. Ferri, M. Zucconi et al.Neurology, June 29, 2011